p75 Neurotrophin Receptor and Glioma Invasion
Author Information
Author(s): Johnston Angela L. M, Lun Xueqing, Rahn Jennifer J, Liacini Abdelhamid, Wang Limei, Hamilton Mark G, Parney Ian F, Hempstead Barbara L, Robbins Stephen M, Forsyth Peter A, Senger Donna L
Primary Institution: University of Calgary
Hypothesis
Is the p75 neurotrophin receptor a critical regulator of glioma invasion?
Conclusion
The study identifies the p75 neurotrophin receptor as a major contributor to the invasive nature of malignant gliomas and suggests it as a potential therapeutic target.
Supporting Evidence
- p75NTR was found to enhance migration and invasion of glioma cells in vitro.
- Expression of p75NTR was detected in 50% of glioma patient specimens.
- Down-regulation of p75NTR reduced glioma cell migration and invasion.
- p75NTR expression was associated with increased invasiveness in vivo.
Takeaway
This study found that a specific receptor in brain cancer cells helps them spread and invade other areas, making the cancer harder to treat.
Methodology
The researchers used a novel invasive glioma mouse model and various biochemical and clinical studies to assess the role of p75NTR in glioma invasion.
Potential Biases
Potential bias in the selection of glioma cell lines and the interpretation of results based on specific experimental conditions.
Limitations
The study primarily focuses on the p75NTR receptor without exploring other potential factors influencing glioma invasion.
Participant Demographics
The study included human glioma patient specimens, with varying grades of gliomas.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website